Skip to main content
U.S. Department of Energy
Office of Scientific and Technical Information

CMTM5 exhibits tumor suppressor activity through promoter methylation in oral squamous cell carcinoma

Journal Article · · Biochemical and Biophysical Research Communications
 [1];  [2];  [1]; ;  [3];  [1];  [2];  [3]
  1. Central Laboratory, Peking University School of Stomatology, Beijing (China)
  2. Center for Human Disease Genomics, Department of Immunology, Key Laboratory of Medical Immunology, Ministry of Health, School of Basic Medical Sciences, Peking University, Beijing (China)
  3. Department of Oral Pathology, Peking University School of Stomatology, Beijing (China)
Highlights: • Down-regulation of CMTM5 expression in OSCC tissues was found. • The promoter methylation status of CMTM5 was measured. • CMTM5-v1 inhibited cell proliferation and migration and induced apoptosis. • CMTM5 might act as a putative tumor suppressor gene in OSCC. - Abstract: Oral squamous cell carcinoma (OSCC) is one of the most common types of malignancies in the head and neck region. CKLF-like MARVEL transmembrane domain-containing member 5 (CMTM5) has been recently implicated as a tumor suppressor gene in several cancer types. Herein, we examined the expression and function of CMTM5 in oral squamous cell carcinoma. CMTM5 was down-regulated in oral squamous cell lines and tumor samples from patients with promoter methylation. Treatment with the demethylating agent 5-aza-2′-deoxycytidine restored CMTM5 expression. In the OSCC cell lines CAL27 and GNM, the ectopic expression of CMTM5-v1 strongly inhibited cell proliferation and migration and induced apoptosis. In addition, CMTM5-v1 inhibited tumor formation in vivo. Therefore, CMTM5 might act as a putative tumor suppressor gene through promoter methylation in oral squamous cell carcinoma.
OSTI ID:
22416414
Journal Information:
Biochemical and Biophysical Research Communications, Journal Name: Biochemical and Biophysical Research Communications Journal Issue: 2 Vol. 447; ISSN 0006-291X; ISSN BBRCA9
Country of Publication:
United States
Language:
English

Similar Records

NDRG2 is a candidate tumor-suppressor for oral squamous-cell carcinoma
Journal Article · Thu Jan 21 23:00:00 EST 2010 · Biochemical and Biophysical Research Communications · OSTI ID:22202352

Epigenetic inactivation of SPINT2 is associated with tumor suppressive function in esophageal squamous cell carcinoma
Journal Article · Mon Mar 10 00:00:00 EDT 2014 · Experimental Cell Research · OSTI ID:22395875

SPARC is down-regulated by DNA methylation and functions as a tumor suppressor in T-cell lymphoma
Journal Article · Thu Mar 15 00:00:00 EDT 2018 · Experimental Cell Research · OSTI ID:23082431